RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Dustin D, Gu G, Beyer AR, Herzog SK, et al. Br J Cancer 2020 Dec 1. pii: 10.1038/s41416-020-01174.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dustin D, Gu G, Beyer AR, Herzog SK, et al. RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br J Cancer 2020 Dec 1. pii: 10.1038/s41416-020-01174.
PMID: 33257837